Schedule 13D ownership disclosure
CASI PHARMACEUTICALS INC
Security class unavailable · CUSIP: 14757U109
Event date: 2020-08-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-223600
- Form type
- SC 13D
- Filer
- CASI Pharmaceuticals, Inc (DE)
- CIK
- CIK 895051
- Filed
- Aug 18, 2020
- Reporting period
- Aug 18, 2020
- Description
- Schedule 13D beneficial ownership